Welcome to our dedicated page for Definitive Healthcare news (Ticker: DH), a resource for investors and traders seeking the latest updates and insights on Definitive Healthcare stock.
Definitive Healthcare Corp. reports developments in healthcare market data, analytics, and commercial intelligence for organizations operating on the business side of healthcare. Its SaaS-based platform and related solutions support use cases such as market selection, go-to-market planning, provider targeting, affiliation analysis, prescription-pattern visibility, Key Opinion Leader identification, and workflow data enrichment.
Recurring news for DH includes quarterly and annual financial results, guidance commentary, customer wins and renewals across life sciences and health-system markets, expansions involving products such as Monocl and Population Intelligence, data-integration use cases, and investor conference presentations. Company updates also describe subscription revenue trends, adjusted profitability measures, cash flow, and commercial execution across new logos and existing customers.
Definitive Healthcare (Nasdaq: DH) has appointed Robert Musslewhite as President, enhancing its Executive Leadership Team during a period of rapid growth. Musslewhite brings extensive healthcare experience, previously leading OptumInsight and serving on Definitive Healthcare's board. With a total addressable market exceeding $10 billion and a unique SaaS platform, the company is set for significant impact in the healthcare industry. His expertise is expected to drive the development of new commercial intelligence solutions.
Definitive Healthcare Corp. has successfully closed its initial public offering, selling 17,888,888 shares of Class A common stock at $27.00 per share. This offering includes the full exercise of the underwriters' option for an additional 2,333,333 shares, yielding approximately $483 million in gross proceeds. The stock began trading on the Nasdaq Global Select Market under the symbol DH on September 15, 2021. Major underwriters include Goldman Sachs and J.P. Morgan.
Definitive Healthcare Corp. has announced the pricing of its initial public offering (IPO) for 15,555,555 shares of Class A common stock at $27.00 per share. The offering allows underwriters a 30-day option to buy an additional 2,333,333 shares. Trading on the Nasdaq Global Select Market under ticker symbol 'DH' is set to start on September 15, 2021, with closure of the offering anticipated on September 17, 2021. Goldman Sachs and J.P. Morgan are leading the underwriting team.